✦ LIBER ✦

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA

✍ Scribed by Douglas, K W; Parker, A N; Hayden, P J; Rahemtulla, A; D'Addio, A; Lemoli, R M; Rao, K; Maris, M; Pagliuca, A; Uberti, J; Scheid, C; Noppeney, R; Cook, G; Bokhari, S W; Worel, N; Mikala, G; Masszi, T; Taylor, R; Treisman, J

Book ID: 120252205
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 297 KB
Volume: 47
Category: Article
ISSN: 0007-1188
DOI: 10.1038/bmt.2011.9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4526 POSTER Safety profile of single-age

4526 POSTER Safety profile of single-agent sunitinib malate from the French Temporary Authorization for Use program (Cohort ATU) in metastatic renal cell carcinoma (MRCC) after failure of treatment with cytokines and gastrointestinal stromal tumor (GIST) patients after failure of imatinib mesylate treatment

✍ Oudard, S.; Negrier, S.; Ferrero, J.M.; Gravis, G.; Blay, J.Y.; Le Cesne, A.; Kr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB